| Icahn School of Medicine at Mount Sinai | |
|---|---|
| Logo placeholder | |
| Location | New York, NY, USA |
| Type | Medical School |
| Website | https://icahn.mssm.edu/ |
| Focus Areas | Alzheimer's Disease, Genomics, Systems Biology |
| Departments | Department of Neuroscience, Department of Genetics and Genomic Sciences, Alzheimer's Disease Research Center |
Icahn School Of Medicine At Mount Sinai is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Icahn School of Medicine at Mount Sinai is a premier academic medical center located in New York City, renowned for its groundbreaking research in neurodegenerative diseases, genomics, and systems biology[1]. Founded in 1963, Mount Sinai has become a leader in Alzheimer's Disease and Frontotemporal Dementia research.
The institution houses the Alzheimer's Disease Research Center (ADRC) and the Ronald M. Loeb Center for Alzheimer's Disease, supporting extensive research programs[2]. Faculty include internationally recognized researchers such as Alison Goate (FTD genetics), Eric Schadt (systems biology), and Bin Zhang (multi-omics).
Mount Sinai is a global leader in the genetics of Alzheimer's Disease and Frontotemporal Dementia[3]. Researchers have identified numerous risk genes including:
The Institute for Precision Medicine at Mount Sinai applies systems biology approaches to understand complex diseases[5]. Researchers integrate genomic, transcriptomic, proteomic, and metabolomic data to develop predictive models of disease progression.
Mount Sinai conducts numerous clinical trials for Alzheimer's Disease and related disorders, bringing novel therapies to patients[6]. The institution participates in the Alzheimer's Disease Neuroimaging Initiative (ADNI) and other large-scale collaborative studies.
| Researcher | Focus Areas |
|---|---|
| Alison Goate | FTD Genetics, [APP[/entities/[app-protein[/entities/[app-protein[/entities/[app-protein--TEMP--/entities)--FIX-- Processing |
| Eric Schadt | Systems Biology, Multi-omics |
| Bin Zhang | Single-cell Genomics, AI/ML |
| others | Various |
The study of Icahn School Of Medicine At Mount Sinai has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.